TITAN PHARMACEUTICALS INC — Director's Dealing 2004

Feb 11, 2004

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTP)
CIK: 0000910267
Period of Report: 2004-02-09

Reporting Person: BUCALO LOUIS R MD (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2004-02-09	Common Stock	M	81755	$.59	Acquired	431986	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2004-02-09	Stock Option (Right to Buy)	$.59	M	81755	Disposed	2004-02-09	Common Stock (81755)	Direct

Footnotes

F1: Not applicable.